Vitiligo. vitiligo
Conditions
Interventions
Intervention 1: In control group: Clobetasol 0.05% cream for topical use over the selected lesion on the left side of the body was given to patient . we recommended that patient use the drug every
Treatment - Drugs
In control group: Clobetasol 0.05% cream for topical use over the selected lesion on the left side of the body was given to patient . we recommended that patient use the drug every other day,once
In interventionl group: Clobetasol 0.05% cream plus 5FU5% cream for topical use over the selected lesion on the right side of the body was given to patient . we recommended that patient use the drug
Sponsors
Isfahan Univercity of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria were as follow: vitiligo patients with at least 2 lesions on the body, >15 years old, lack of follicular pigmentation (score=0), lack of white hair over the lesion and disease stability within the last 6 months. Exclusion criteria were as follow: those who had recieved topical medication for at least 1 month and systemic medication or phototherapy for at least 3 months prior to inclusion; past medical history of liver, kidney and hematologic disorders; the vitiligo lesions on the face, genitalia or acral areas; pregnancy or lactation and the segmental subtype. Patients were instructed about the study protocol, possible side effects and a written informed consent was taken from all patients before enrollment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesion of vitiligo. Timepoint: End of three months. Method of measurement: Pigmentation score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythema,atrophy,erosion. Timepoint: any time during treatmrnt. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr.zabihollah shahmoradi
Isfahan Univercity of Medical Sciences
Outcome results
None listed